SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (6154)1/24/1999 5:33:00 PM
From: VLAD  Read Replies (1) of 7041
 
After sinking all this time and money into Vasomax, SGP feels that most of its initial investment can be recovered via initial sales in new markets to be launched. The placebo effect is in essence what they are banking on. It would be financial suicide at this point to withdraw their launches as they have a contract with Zonagen and they will make money intitially on Vasomax during its release.

We all(except you) know that once the product is on the market in any given country for an extended period of time (>6months) it will prove to be marginal at best in its success but considering that a sugar pill would have marginal success its not saying much.

When will you realize that this really is not an effective oral drug and will be no competition for Viagra especially when it costs the same amount of money?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext